Europe Sophorolipid and Rhamnolipid Market
Europe Sophorolipid and Rhamnolipid Market is growing at a CAGR of 6.0% to reach US$ 193.06 million by 2030 from US$ 120.83 million in 2022 by Type and Application.

Published On: Feb 2024

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Sophorolipid and Rhamnolipid Market

At 6.0% CAGR, the Europe Sophorolipid and Rhamnolipid Market is Projected to be Worth US$ 193.06 Million by 2030, Says Business Market Insights

According to Business Market Insights' research, the Europe sophorolipid and rhamnolipid market was valued at US$ 120.83 in 2022 and is expected to reach US$ 193.06 million by 2030, registering a CAGR of 6.0% from 2022 to 2030. Strong growth of personal care & cosmetics industry and growing demand from detergents & cleaning products industry are among the critical factors attributed to the Europe sophorolipid and rhamnolipid market expansion.

The personal care & cosmetics industry is growing significantly as people increasingly buy personal care and beauty products. In recent years, there has been a growth in the use of different cosmetic products among both male and female consumers in their daily routines. The personal care and cosmetic product manufacturers are focusing on product branding, advertising, and new product launch strategies to increase their product sales. The e-commerce industry in many countries has been witnessing a rising growth curve, further boosting the sales of personal care and cosmetic products across the globe.

Further, rising awareness regarding the use of chemical-based ingredients in personal care and cosmetics products is driving the demand for biosurfactants. Nowadays, biosurfactants such as sophorolipids and rhamnolipids are gaining more attention due to environmentally friendly, biodegradable, non-toxic, and less side effects. Sophorolipids and rhamnolipids are used in personal care and cosmetics products such as shampoos, conditioners, shower gels, face washes, creams, body wash, facial cleansers, lotions, and others. Hence, the strong growth of the personal care & cosmetics industry is expected to offer lucrative opportunities for the Europe sophorolipid and rhamnolipid market during the forecast period.

On the contrary, high cost of sophorolipid and rhamnolipid production hamper the growth Europe sophorolipids and rhamnolipids market.

Based on type, the Europe sophorolipid and rhamnolipid market is bifurcated into sophorolipid and rhamnolipid. The sophorolipid segment held 79.5% share of the Europe sophorolipid and rhamnolipid market in 2022, amassing US$ 96.02 million. It is projected to garner US$ 151.38 million by 2030 to expand at 5.9% CAGR during 2022–2030.

In terms of application, the Europe sophorolipid and rhamnolipid market is segmented into household detergents, personal care, industrial and institutional cleaners, food processing, oilfield chemicals, leather processing, agriculture, pharmaceuticals, and others. The household detergents segment held 38.4% share of the Europe sophorolipid and rhamnolipid market in 2022, amassing US$ 46.38 million. It is projected to garner US$ 75.24 million by 2030 to expand at 6.2% CAGR during 2022–2030.

Based on country, the Europe sophorolipid and rhamnolipid market is categorized into Germany, France, Italy, the UK, Russia, and the Rest of Europe. The Rest of Europe held 26.1% share of Europe sophorolipid and rhamnolipid market in 2022, amassing US$ 31.55 million. It is projected to garner US$ 45.59 million by 2030 to expand at 4.7% CAGR during 2022–2030.

Key players operating in the Europe sophorolipid and rhamnolipid market are Saraya Co Ltd, Evonik Industries AG, Givaudan SA, Godrej Industries Ltd, Holiferm Ltd, Stepan Co, Deguan Biosurfactant Supplier, Dow Inc, and Jeneil Bioproducts GmbH, among others.

  • In 2022, Evonik announced the investment in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The investment at the Slovenská Ľupča site in Slovakia strengthens Evonik's partnership with the consumer goods group Unilever, which began in 2019. At the same time the investment allows Evonik to further expand its market position in the growth market for biosurfactants. The new plant is scheduled to come on stream in two years.
  • In 2022, Evonik launched a rhamnolipid, Rewoferm RL 100. This biosurfactant meets demands for low-emission, low-impact cleaning products that enable a circular economy. Rewoferm RL 100 is produced from renewable feedstocks sourced in Slovakia, where its new biosurfactant plant is based and is fully biodegradable while providing excellent cleaning performance.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com